What are the responsibilities and job description for the Psychiatrist - Greenbrook Mental Wellness Centers position at Neuronetics, Inc.?
TMS NeuroHealth Texas PLLC (a division of Greenbrook TMS NeuroHealth Centers Services, LLC)
IS SEEKING PART-TIME (1099) BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRISTS FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN BRYKER WOODS, TX.
Greenbrook now operates 95 centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.
WHY JOIN?
At the forefront of mental health care, Greenbrook operates 95 U.S. centers offering cutting-edge, FDA-cleared TMS (targeted electromagnetic stimulation for mood regulation) and Spravato® (for treatment-resistant depression and MDD with suicidal thoughts/actions). This innovative approach has already touched the lives of over 40,000 patients, with more than 1.3 million treatments administered. To learn our WHY click here | Patient stories on HOW we transform lives click here | To access provider information, click here
Over 16 million Americans are affected by depression. Greenbrook is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
We are committed to providing equal employment opportunities to individuals with disabilities and protected veterans.
GBSP25
About Us
Neuronetics, Inc. is a leading mental healthcare company, now encompassing Greenbrook TMS as a subsidiary. This strategic acquisition unites Neuronetics' innovative NeuroStar® Advanced Therapy (TMS) technology with Greenbrook's extensive network of over 95 U.S. treatment centers. The combined company provides FDA-cleared NeuroStar® TMS and Spravato® treatments for major depressive disorder (MDD) and treatment-resistant depression. With a strengthened nationwide footprint, Neuronetics is dedicated to significantly expanding patient access to these crucial therapies, integrating advanced technology with established clinical expertise to improve patient outcomes and drive growth within the mental health sector.
IS SEEKING PART-TIME (1099) BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRISTS FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN BRYKER WOODS, TX.
Greenbrook now operates 95 centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.
WHY JOIN?
- Expand your professional knowledge & clinical skillset
- Make a difference in the lives of patients using innovative treatment options
- Enjoy flexibility with respect to scheduling (no nighttime, weekend, or on-call hours) and hours worked per week
- Benefit from an additional income opportunity with competitive pay
- Receive specialized TMS certification and training
- Work alongside our experienced management & clinical leadership team
At the forefront of mental health care, Greenbrook operates 95 U.S. centers offering cutting-edge, FDA-cleared TMS (targeted electromagnetic stimulation for mood regulation) and Spravato® (for treatment-resistant depression and MDD with suicidal thoughts/actions). This innovative approach has already touched the lives of over 40,000 patients, with more than 1.3 million treatments administered. To learn our WHY click here | Patient stories on HOW we transform lives click here | To access provider information, click here
Over 16 million Americans are affected by depression. Greenbrook is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
- Applicants must be authorized to work for any employer in the US. We are unable to sponsor or assume responsibility for employment visa/work authorization at this time.
We are committed to providing equal employment opportunities to individuals with disabilities and protected veterans.
GBSP25
About Us
Neuronetics, Inc. is a leading mental healthcare company, now encompassing Greenbrook TMS as a subsidiary. This strategic acquisition unites Neuronetics' innovative NeuroStar® Advanced Therapy (TMS) technology with Greenbrook's extensive network of over 95 U.S. treatment centers. The combined company provides FDA-cleared NeuroStar® TMS and Spravato® treatments for major depressive disorder (MDD) and treatment-resistant depression. With a strengthened nationwide footprint, Neuronetics is dedicated to significantly expanding patient access to these crucial therapies, integrating advanced technology with established clinical expertise to improve patient outcomes and drive growth within the mental health sector.